etravirine has been researched along with diosmin in 1 studies
| Studies (etravirine) | Trials (etravirine) | Recent Studies (post-2010) (etravirine) | Studies (diosmin) | Trials (diosmin) | Recent Studies (post-2010) (diosmin) |
|---|---|---|---|---|---|
| 572 | 90 | 321 | 540 | 106 | 243 |
| Protein | Taxonomy | etravirine (IC50) | diosmin (IC50) |
|---|---|---|---|
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 3.89 | |
| Aurora kinase B | Homo sapiens (human) | 9.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baidya, ATK; Das, B; Kumar, R; Mathew, AT; Yadav, AK | 1 |
1 review(s) available for etravirine and diosmin
| Article | Year |
|---|---|
Structural modification aimed for improving solubility of lead compounds in early phase drug discovery.
Topics: Drug Discovery; Hydrogen Bonding; Molecular Structure; Prodrugs; Solubility | 2022 |